GTCM
QTTB icon

Gyon Technologies Capital Management’s Q32 Bio QTTB Stock Holding History

Gyon Technologies Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-729
Closed -$199K – 310
2020
Q2 		$199K Buy
+729
New +$194K 0.48% 64

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gyon Technologies Capital Management's QTTB Position: Q3 2020 in Review

Gyon Technologies Capital Management sold out of Q32 Bio (QTTB) in Q3 2020, closing a stake of 729 shares — an estimated $199K sold.

Gyon Technologies Capital Management first reported a position in QTTB in Q2 2020 and held it in 1 quarter. The position peaked at $199K in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q3 2020.

  • Gyon Technologies Capital Management reported no remaining Q32 Bio position as of Q3 2020 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 729 Q32 Bio shares in Q3 2020, an estimated $199K.
  • Gyon Technologies Capital Management first reported a position in Q32 Bio in Q2 2020 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Q32 Bio position peaked at $199K in Q2 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2020.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.